Fidelity Investments
CANC icon

Fidelity Investments’s Tema Oncology ETF CANC Stock Holding History

Fidelity Investments’s Portfolio CANC Stock Details CANC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2
Closed -$49 – 5333
2024
Q4 		$49 Buy
+2
New +$54 ﹤0.01% 5188

Other funds holding CANC

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return

Fidelity Investments's CANC Position: Q1 2025 in Review

Fidelity Investments sold out of Tema Oncology ETF (CANC) in Q1 2025, closing a stake of 2 shares — an estimated $49 sold.

Fidelity Investments first reported a position in CANC in Q4 2024 and held it in 1 quarter. The position peaked at $49 in Q4 2024. 6 funds tracked by Wall St. Rank hold CANC as of Q1 2025.

  • Fidelity Investments reported no remaining Tema Oncology ETF position as of Q1 2025 after selling out during the quarter.
  • Fidelity Investments sold 2 Tema Oncology ETF shares in Q1 2025, an estimated $49.
  • Fidelity Investments first reported a position in Tema Oncology ETF in Q4 2024 and held it in 1 quarter.
  • Fidelity Investments's Tema Oncology ETF position peaked at $49 in Q4 2024.
  • 6 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q1 2025.

Based on Fidelity Investments's 13F filing for Q1 2025, filed 12 May 2025.